FORMULARY WATCH

FDA ACTIONS

TODAY'S HEADLINES

FDA approvals: First 2-drug combo for advanced melanoma

By Christine Blank
The first 2-drug combo for advanced melanoma was announced. Read about the approval of Opdivo and Yervoy and 5 other FDA actions. Read more

Debate the Ethics of Drug Price Gouging

Don't miss this timely & vital conversation at the 2015 Drug Pricing & Reimbursement Strategies Summit. Network with leaders from Pfizer, BMS, Genentech, Allergan, Novartis, J&J, Biogen & more! Learn more.

FDA expands use for lung cancer drug

by Christine Blank
FDA has granted accelerated approval for Opdivo for expanded use for the treatment of advanced non-small cell lung cancer. Details

CONTINUING EDUCATION

October 2015
MTM essentials for cold, flu, and sinusitis management

Session code: 15DT35-PTK48
This month’s CE activity is part of the CPE series, "Medication Therapy Management for the Patient with Respiratory Disease." From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to compare and contrast the common cold, influenza, and sinusitis, and discuss the role of the pharmacist as the medication expert for various treatment options and as a source to triage patients when needed.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT35-PTK48.
Copy the session code — 15DT35-PTK48 — before logging into the Online CE Center. When the page for the Online CE Center opens, paste the session code into the appropriate field, under your NABP ID.

How Express Scripts will manage pricey cholesterol drugs

by Christine Blank
After criticism about the price of Praluent and Repatha, Express Scripts announced that it will add both drugs to its national formulary to reduce costs. Here's how

October 14, 2015